Pfizer Inc. (PFE)
NYSE: PFE · IEX Real-Time Price · USD
+0.26 (0.91%)
At close: Jul 12, 2024, 4:03 PM
+0.03 (0.10%)
After-hours: Jul 12, 2024, 7:59 PM EDT

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of $163.88 billion. The enterprise value is $221.49 billion.

Market Cap 163.88B
Enterprise Value 221.49B

Important Dates

The next confirmed earnings date is Tuesday, July 30, 2024, before market open.

Earnings Date Jul 30, 2024
Ex-Dividend Date Jul 26, 2024

Share Statistics

Pfizer has 5.67 billion shares outstanding. The number of shares has decreased by -0.52% in one year.

Shares Outstanding 5.67B
Shares Change (YoY) -0.52%
Shares Change (QoQ) +0.05%
Owned by Insiders (%) 0.05%
Owned by Institutions (%) 68.43%
Float 5.66B

Valuation Ratios

PE Ratio n/a
Forward PE 11.49
PS Ratio 2.97
Forward PS 2.59
PB Ratio 1.78
P/FCF Ratio 32.10
PEG Ratio 0.26
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 47.20, with an EV/FCF ratio of 43.38.

EV / Earnings n/a
EV / Sales 4.02
EV / EBITDA 47.20
EV / EBIT n/a
EV / FCF 43.38

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.75.

Current Ratio 1.05
Quick Ratio 0.57
Debt / Equity 0.75
Debt / EBITDA 14.82
Debt / FCF 13.62
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -0.30% and return on invested capital (ROIC) is -1.11%.

Return on Equity (ROE) -0.30%
Return on Assets (ROA) -0.10%
Return on Capital (ROIC) -1.11%
Revenue Per Employee $626,068
Profits Per Employee -$3,511
Employee Count 88,000
Asset Turnover 0.25
Inventory Turnover 2.30


Income Tax -1.54B
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.64% in the last 52 weeks. The beta is 0.63, so Pfizer's price volatility has been lower than the market average.

Beta (5Y) 0.63
52-Week Price Change -19.64%
50-Day Moving Average 28.22
200-Day Moving Average 28.57
Relative Strength Index (RSI) 59.90
Average Volume (20 Days) 30,514,608

Short Selling Information

The latest short interest is 59.89 million, so 1.06% of the outstanding shares have been sold short.

Short Interest 59.89M
Short Previous Month 75.97M
Short % of Shares Out 1.06%
Short % of Float 1.06%
Short Ratio (days to cover) 1.74

Income Statement

In the last 12 months, Pfizer had revenue of $55.09 billion and -$309.00 million in losses. Loss per share was -$0.05.

Revenue 55.09B
Gross Profit 31.65B
Operating Income -1.79B
Pretax Income -1.85B
Net Income -309.00M
EBIT -1.85B
Loss Per Share -$0.05
Full Income Statement

Balance Sheet

The company has $11.93 billion in cash and $69.54 billion in debt, giving a net cash position of -$57.61 billion or -$10.17 per share.

Cash & Cash Equivalents 11.93B
Total Debt 69.54B
Net Cash -57.61B
Net Cash Per Share -$10.17
Equity (Book Value) 92.28B
Book Value Per Share 16.29
Working Capital 1.92B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $8.58 billion and capital expenditures -$3.47 billion, giving a free cash flow of $5.11 billion.

Operating Cash Flow 8.58B
Capital Expenditures -3.47B
Free Cash Flow 5.11B
FCF Per Share $0.90
Full Cash Flow Statement


Gross margin is 57.44%, with operating and profit margins of -3.25% and -0.56%.

Gross Margin 57.44%
Operating Margin -3.25%
Pretax Margin -3.35%
Profit Margin -0.56%
EBITDA Margin 8.52%
EBIT Margin -3.35%
FCF Margin 9.27%

Dividends & Yields

This stock pays an annual dividend of $1.68, which amounts to a dividend yield of 5.81%.

Dividend Per Share $1.68
Dividend Yield 5.81%
Dividend Growth (YoY) 2.45%
Years of Dividend Growth 13
Payout Ratio n/a
Buyback Yield 0.52%
Shareholder Yield 6.33%
Earnings Yield -0.19%
FCF Yield 3.12%
Dividend Details

Analyst Forecast

The average price target for Pfizer is $35.69, which is 23.41% higher than the current price. The consensus rating is "Buy".

Price Target $35.69
Price Target Difference 23.41%
Analyst Consensus Buy
Analyst Count 14
Revenue Growth Forecast (5Y) 1.48%
EPS Growth Forecast (5Y) 50.72%
Stock Forecasts

Stock Splits

The last stock split was on November 17, 2020. It was a forward split with a ratio of 1054:1000.

Last Split Date Nov 17, 2020
Split Type Forward
Split Ratio 1054:1000


Pfizer has an Altman Z-Score of 1.77 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.77
Piotroski F-Score 2